Schizophrenia pathophysiology: are we any closer to a complete model?

作者: Shaheen E Lakhan , Karen F Vieira

DOI: 10.1186/1744-859X-8-12

关键词:

摘要: Schizophrenia, a severe brain disorder that involves hallucinations, disordered thinking and deficiencies in cognition, has been studied for decades order to determine the early events lead this neurological disorder. In review, we interpret developmental genetic models have proposed treatment options associated with these models. Schizophrenia was initially thought be hereditary based on studies of high incidence certain families. Additionally, specific genes such as ZDHHC8 DTNBP1 seem suggest susceptibility onset However, no single gene variation linked schizophrenia, recent evidence sporadic cases schizophrenia refutes genetics being singular cause disease. addition, current data suggests neurodevelopmental or environmental causes viral infections prenatal/perinatal complications. Before any can understood, however, multiple cognitive neuroscientific accommodate from many biomedical research fields should considered, unfortunately, are earliest stages development. Consequently, it makes us question whether closer an adequate understanding pathophysiology schizophrenia.

参考文章(42)
Y. Iizuka, Y. Sei, D. R. Weinberger, R. E. Straub, Evidence That the BLOC-1 Protein Dysbindin Modulates Dopamine D2 Receptor Internalization and Signaling But Not D1 Internalization The Journal of Neuroscience. ,vol. 27, pp. 12390- 12395 ,(2007) , 10.1523/JNEUROSCI.1689-07.2007
Taku Nagai, Rina Murai, Kanae Matsui, Hiroyuki Kamei, Yukihiro Noda, Hiroshi Furukawa, Toshitaka Nabeshima, Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors. Psychopharmacology. ,vol. 202, pp. 315- 328 ,(2009) , 10.1007/S00213-008-1240-6
Masanari Itokawa, Makoto Arai, Shuhei Kato, Yoko Ogata, Aizo Furukawa, Seiichi Haga, Hiroshi Ujike, Ichiro Sora, Kazuhiko Ikeda, Takeo Yoshikawa, Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans. Neuroscience Letters. ,vol. 347, pp. 202- 204 ,(2003) , 10.1016/S0304-3940(03)00718-3
A Y Guo, J Sun, B P Riley, D L Thiselton, K S Kendler, Z Zhao, The dystrobrevin-binding protein 1 gene: features and networks. Molecular Psychiatry. ,vol. 14, pp. 18- 29 ,(2009) , 10.1038/MP.2008.88
Ralf Brisch, Hans-Gert Bernstein, Dieter Krell, Henrik Dobrowolny, Hendrik Bielau, Johann Steiner, Tomasz Gos, Sieglinde Funke, Renate Stauch, Sven Knüppel, Bernhard Bogerts, Dopamine–glutamate abnormalities in the frontal cortex associated with the catechol-O-methyltransferase (COMT) in schizophrenia Brain Research. ,vol. 1269, pp. 166- 175 ,(2009) , 10.1016/J.BRAINRES.2009.02.039
Daniel R. Weinberger, Implications of Normal Brain Development for the Pathogenesis of Schizophrenia Archives of General Psychiatry. ,vol. 44, pp. 660- 669 ,(1987) , 10.1001/ARCHPSYC.1987.01800190080012
Christos Pantelis, Paul Maruff, The cognitive neuropsychiatric approach to investigating the neurobiology of schizophrenia and other disorders. Journal of Psychosomatic Research. ,vol. 53, pp. 655- 664 ,(2002) , 10.1016/S0022-3999(02)00434-8
Christos Pantelis, Christos Pantelis, Murat Yücel, Stephen J. Wood, Patrick D. McGorry, Dennis Velakoulis, Early and late neurodevelopmental disturbances in schizophrenia and their functional consequences Australian and New Zealand Journal of Psychiatry. ,vol. 37, pp. 399- 406 ,(2003) , 10.1046/J.1440-1614.2003.01193.X